The dominant CD8+ cell clonotype in the infusate identified by its unique CDR3-beta was also dominant in regressing metastases (Fig. 3c)31, implicating infused CD8+ cells as the likely mediators of tumor regression. This evidence concerns the gene CD8A and neoplasm.